Hepatic estrogen receptor α improves hepatosteatosis through upregulation of small heterodimer partner

Journal of Hepatology

Volumn 63, Issue 1, 2015, Pages 183-190

  Wang, Xiaolin ^a   Lu, Yan ^a   Wang, E ^a   Zhang, Zhijian ^a   Xiong, Xuelian ^a   Zhang, Huijie ^b   Lu, Jieli ^a   Zheng, Sheng ^a   Yang, Jian ^a   Xia, Xuefeng ^c   Yang, Shuyu ^b   Li, Xiaoying ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XIAMEN UNIVERSITY   (China)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Shanghai Institute of Immunology   (China)

Author keywords

ERa; Estrogen; FXR; Hepatosteatosis; SHP

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; FARNESOID X RECEPTOR; HETERODIMER; SHORT HAIRPIN RNA; SMALL HETERODIMER PARTNER; TAMOXIFEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CELL RECEPTOR; DNA; ESTROGEN RECEPTOR ALPHA, HUMAN; NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HIP CIRCUMFERENCE; HOMEOSTASIS; HUMAN; LIPID LIVER LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OBESITY; OVARIECTOMY; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; GENETICS; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ANIMALS; CELLS, CULTURED; DNA; ESTROGEN RECEPTOR ALPHA; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84931561712     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.02.029     Document Type: Article

References (41)

1. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
2. S. Bellentani, F. Scaglioni, M. Marino, and G. Bedogni Epidemiology of non-alcoholic fatty liver disease Dig Dis 28 2010 155 161
3. Y. Gutierrez-Grobe, G. Ponciano-Rodríguez, M.H. Ramos, M. Uribe, and N. Méndez-Sánchez Prevalence of non-alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens Ann Hepatol 9 2010 402 409
4. A. Suzuki, and M.F. Abdelmalek Nonalcoholic fatty liver disease in women Womens Health (Lond Engl) 5 2009 191 203
5. P.A. Heine, J.A. Taylor, G.A. Iwamoto, D.B. Lubahn, and P.S. Cooke Increased adipose tissue in male and female estrogen receptor-alpha knockout mice Proc Natl Acad Sci U S A 97 2000 12729 12734
6. G. Bryzgalova, H. Gao, B. Ahren, J.R. Zierath, D. Galuska, and T.L. Steiler Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver Diabetologia 49 2006 588 597
7. F. Mauvais-Jarvis Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity Trends Endocrinol Metab 22 2011 24 33
8. A.M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, and V. Bittner Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial Ann Intern Med 138 2003 1 9
9. K.L. Margolis, D.E. Bonds, R.J. Rodabough, L. Tinker, L.S. Phillips, and C. Allen Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial Diabetologia 47 2004 1175 1187
10. S. Fiorucci, G. Rizzo, A. Donini, E. Distrutti, and L. Santucci Targeting farnesoid X receptor for liver and metabolic disorders Trends Mol Med 13 2007 298 309
11. M. Watanabe, S.M. Houten, L. Wang, A. Moschetta, D.J. Mangelsdorf, and R.A. Heyman Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J Clin Invest 113 2004 1408 1418
12. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
13. Y. Lu, Z. Ma, Z. Zhang, X. Xiong, X. Wang, and H. Zhang Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice Gut 63 2014 170 178
14. Z.X. Yang, W. Shen, and H. Sun Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease Hepatol Int 4 2010 741 748
15. M. Fuchs Non-alcoholic fatty liver disease: the bile cid-activated farnesoid x receptor as an emerging treatment target J Lipids 2012 2012 934396
16. H.J. Zhang, X.F. Zhang, Z.M. Ma, L.L. Pan, Z. Chen, and H.W. Han Irisin is inversely associated with intrahepatic triglyceride contents in obese adults J Hepatol 59 2013 557 562
17. W.N. William Jr, J.V. Heymach, E.S. Kim, and S.M. Lippman Molecular targets for cancer chemoprevention Nat Rev Drug Discov 8 2009 213 225
18. S. Nilsson, S. Mäkelä, E. Treuter, M. Tujague, J. Thomsen, and G. Andersson Mechanisms of estrogen action Physiol Rev 81 2001 1535 1565
19. B. Goodwin, S.A. Jones, R.R. Price, M.A. Watson, D.D. McKee, and L.B. Moore A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis Mol Cell 6 2000 517 526
20. S. Dauvois, R. White, and M.G. Parker The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling J Cell Sci 106 1993 1377 1388
21. K.E. Weis, K. Ekena, J.A. Thomas, G. Lazennec, and B.S. Katzenellenbogen Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein Mol Endocrinol 10 1996 1388 1398
22. Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, and M. Brown Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 103 2000 843 852
23. M.C. Carr The emergence of the metabolic syndrome with menopause J Clin Endocrinol Metab 88 2003 2404 2411
24. T.M. D'Eon, S.C. Souza, M. Aronovitz, M.S. Obin, S.K. Fried, and A.S. Greenberg Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways J Biol Chem 280 2005 35983 35991
25. Z. He, S.S. Zhang, Q.Y. Meng, S.W. Li, H.H. Zhu, and M.A. Raquil Shp2 controls female body weight and energy balance by integrating leptin and estrogen signals Mol Cell Biol 32 2012 1867 1878
26. S. Musatov, W. Chen, D.W. Pfaff, C.V. Mobbs, X.J. Yang, and D.J. Clegg Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome Proc Natl Acad Sci U S A 104 2007 2501 2506
27. J.P. Tiano, V. Delghingaro-Augusto, C. Le May, S. Liu, M.K. Kaw, and S.S. Khuder Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes J Clin Invest 21 2011 3331 3342
28. L. Zhu, W.C. Brown, Q. Cai, A. Krust, P. Chambon, and O.P. McGuinness Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance Diabetes 62 2013 424 434
29. K. Lai, D.C. Harnish, and M.J. Evans Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner J Biol Chem 278 2003 36418 36429
30. Y.K. Lee, H. Dell, D.H. Dowhan, M. Hadzopoulou-Cladaras, and D.D. Moore The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression Mol Cell Biol 20 2000 187 195
31. A. Båvner, S. Sanyal, J.A. Gustafsson, and E. Treuter Transcriptional corepression by SHP: molecular mechanisms and physiological consequences Trends Endocrinol Metab 16 2005 478 488
32. J.Y. Chiang Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms J Hepatol 40 2004 539 551
33. D. Chanda, J.H. Park, and H.S. Choi Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner Endocr J 55 2008 253 268
34. Y.D. Kim, K.G. Park, Y.S. Lee, Y.Y. Park, D.K. Kim, and B. Nedumaran Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP Diabetes 57 2008 306 314
35. K. Boulias, N. Katrakili, K. Bamberg, P. Underhill, A. Greenfield, and I. Talianidis Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP EMBO J 24 2005 2624 2633
36. J. Huang, J. Iqbal, P.K. Saha, J. Liu, L. Chan, and M.M. Hussain Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver Hepatology 46 2007 147 157
37. A. Milona, B.M. Owen, J.F. Cobbold, E.C. Willemsen, I.J. Cox, and M. Boudjelal Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function Hepatology 52 2010 1341 1349
38. C.J. Park, Z. Zhao, C. Glidewell-Kenney, M. Lazic, P. Chambon, and A. Krust Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice J Clin Invest 121 2011 604 612
39. S.I. Han, Y. Komatsu, A. Murayama, K.R. Steffensen, Y. Nakagawa, and Y. Nakajima ER ligands ameliorate fatty liver through a non-classical ER/LXR pathway Hepatology 59 2014 1791 1802
40. A.D. Adamson, S. Friedrichsen, S. Semprini, C.V. Harper, J.J. Mullins, and M.R. White Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling Endocrinology 149 2008 687 694
41. S. Mandal, and J.R. Davie Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells J Cell Physiol 224 2010 28 32